Facts about Alzheimer’s and Dementia 

Alzheimer’s disease affects nearly 7 million people living in the United States, and is a leading cause of death among people 65 and older according to the Alzheimer’s Association. While Alzheimer’s and related dementias contribute to a significant collection of the population, there is still more research to be conducted in order to find treatments, especially for those with early Alzheimer’s disease or mild cognitive impairment.  

Review the facts about Alzheimer’s below to understand more about how it impacts overall health and how clinical research can support improved quality of life for those suffering from the cognitive impairment caused by this disease.  

Participate in Alzheimer’s Clinical Trials 

Alzheimer’s and dementia research are crucial to understanding how new potential innovations and treatments may halt the progression of this disease, especially as more Americans age over 65. The Alzheimer’s Association estimates that by 2050, those affected by “Alzheimer’s may grow to a projected 12.7 million,” without the intervention of scientific research. Clinical trials focused on potential treatment options for Alzheimer’s becomes even more important when reviewing these figures.  

Clinical trials are crucial for developing new treatments and understanding Alzheimer’s better. Participating in clinical trials for Alzheimer’s is a proactive way to contribute to advancements in clinical research and neurological disorder research. By joining a trial, you or your loved one may gain access to the latest investigational therapies and contribute to broader medical knowledge that can benefit others with the condition. 

Why Participate in an Alzheimer’s Disease Trial 

As with many chronic conditions, early detection is key to finding treatments that may help reduce or halt the progression. Alzheimer’s research continues to be at the forefront for many qualified researchers and physicians, especially with a larger population of the United States growing older and potentially developing Alzheimer’s disease. Clinical trials, especially for underrepresented communities, are vitally important to understanding some of the first symptoms, increased risk factors, the impacts of functional impairment, and more about Alzheimer’s disease.